Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Antifungal Agents

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...

Candidiasis

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...

Anthelminthic Agents

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...

Antiprotozoal Agents

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...

Skin Diseases and Disorders

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Response to 'Darier disease in Israel: combined evaluation of genetic and neuropsychiatric aspects': reply from the authors.

The British journal of dermatology·2016

Same author

An open comparative study of nail drilling as adjunctive treatment for toenail onychomycosis (.).

The Journal of dermatological treatment·2016

Same author

Incidence and lifetime costs of injuries in the United States.

Injury prevention : journal of the International Society for Child and Adolescent Injury Prevention·2015

Same author

Darier disease in Israel: combined evaluation of genetic and neuropsychiatric aspects.

The British journal of dermatology·2015

Same author

When is onychomycosis onychomycosis? A cross-sectional study of fungi in normal-appearing nails.

The British journal of dermatology·2014

Same author

Clinical comparison and complete cure rates of Terbinafine efficacy in affected onychomycotic toenails.

Journal of the European Academy of Dermatology and Venereology : JEADV·2014

Search research articles

Related Experiment Video

Updated: Jul 3, 2026

Assessing the Putative Anticryptococcal Properties of Crude and Clarified Extracts from Mollusks

Assessing the Putative Anticryptococcal Properties of Crude and Clarified Extracts from Mollusks

Published on: December 2, 2022

Griseofulvin and its uses.

E Finkelstein¹, B Amichai, M H Grunwald

¹Department of Dermatology, Soroka Medical Center, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

International Journal of Antimicrobial Agents

|April 1, 1996

Summary

This summary is machine-generated.

Griseofulvin is an antifungal medication commonly used for skin infections. This review examines its effectiveness and applications beyond treating dermatophyte infections.

More Related Videos

Fabrication and Characterization of Griffithsin-modified Fiber Scaffolds for Prevention of Sexually Transmitted Infections

Fabrication and Characterization of Griffithsin-modified Fiber Scaffolds for Prevention of Sexually Transmitted Infections

Published on: October 31, 2017

Related Experiment Videos

Last Updated: Jul 3, 2026

Assessing the Putative Anticryptococcal Properties of Crude and Clarified Extracts from Mollusks

Assessing the Putative Anticryptococcal Properties of Crude and Clarified Extracts from Mollusks

Published on: December 2, 2022

Fabrication and Characterization of Griffithsin-modified Fiber Scaffolds for Prevention of Sexually Transmitted Infections

Fabrication and Characterization of Griffithsin-modified Fiber Scaffolds for Prevention of Sexually Transmitted Infections

Published on: October 31, 2017

Area of Science:

Mycology
Dermatology
Pharmacology

Background:

Griseofulvin has a long history of use, spanning three decades.
It is primarily recognized for its efficacy in treating dermatophyte infections.

Purpose of the Study:

To review the established applications of griseofulvin.
To explore and document the use of griseofulvin in treating conditions beyond dermatophytosis.

Main Methods:

Literature review of scientific articles and clinical studies.
Analysis of pharmacological data and treatment outcomes.
Synthesis of information on griseofulvin's therapeutic potential.

Main Results:

Griseofulvin remains a key treatment for fungal skin conditions.
Evidence suggests potential utility in other medical contexts, though specific details require further elaboration.
The review consolidates existing knowledge and highlights areas for future research.

Conclusions:

Griseofulvin's role in treating dermatophyte infections is well-established.
Further investigation into its broader therapeutic applications is warranted.
This review provides a foundation for understanding griseofulvin's expanded medical uses.